The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,211,058 in first-year total cost, median $153,166.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-1 (A1)]14
Most frequent institutions
- DANA-FARBER CANCER INST2
- UNIVERSITY OF CALIFORNIA, SAN DIEGO2
- BRIGHAM AND WOMEN'S HOSPITAL1
- INDIANA UNIVERSITY INDIANAPOLIS1
- ROCKEFELLER UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Defining a Stromal Signature that Facilitates Progression of Lethal Cancers1R50CA211543-01A1 | GASCARD, PHILIPPE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $245,738 | ZCA1 |
| 2019 | Platform and portal development for accessible, reproducible cancer genomics research1R50CA243876-01 | LIEFELD, JOHN THEODORE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $210,436 | ZCA1 |
| 2019 | Functions of Cyclin/CDK complexes in development and cancer1R50CA243769-01 | GENG, YAN | DANA-FARBER CANCER INST, MA | $179,618 | ZCA1 |
| 2019 | Gut microbiota-derived signaling in liver carcinogenesis and cancer treatment1R50CA243787-01 | HU, YING | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $177,278 | ZCA1 |
| 2019 | Validation of EP400 downstream effectors and potential therapeutic targets in Merkel cell carcinoma1R50CA243777-01 | CHENG, JINGWEI | DANA-FARBER CANCER INST, MA | $163,938 | ZCA1 |
| 2019 | Research Specialist in Cancer Systems Biology1R50CA243783-01 | TYSON, DARREN R | VANDERBILT UNIVERSITY, TN | $156,204 | ZCA1 |
| 2019 | Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy1R50CA243693-01 | FATH, MELISSA ANN | UNIVERSITY OF IOWA, IA | $155,127 | ZCA1 |
| 2019 | Molecular Mechanisms of Chemotherapy-Induced Cognitive Dysfunction1R50CA243887-01 | MOHAMMAD, KHALID S | INDIANA UNIVERSITY INDIANAPOLIS, IN | $151,204 | ZCA1 |
| 2019 | Investigating Cancer-Specific Long Noncoding RNAs for Early Cancer Detection1R50CA243899-01 | HART, JONATHAN ROSS | SCRIPPS RESEARCH INSTITUTE, THE, CA | $144,678 | ZCA1 |
| 2019 | The interplay of the CST complex and telomerase at human telomeres1R50CA243771-01 | TAKAI, HIROYUKI | ROCKEFELLER UNIVERSITY, NY | $142,433 | ZCA1 |
| 2019 | Applying Molecular and Functional Genomics to Identify Biomarkers for Diagnosing and Treating Cancer1R50CA243690-01 | GUMIREDDY, KIRANMAI | WISTAR INSTITUTE, PA | $138,169 | ZCA1 |
| 2019 | Innovative approaches for the advancement of glioblastoma therapies1R50CA243706-01 | NOWICKI, MICHAL OSKAR | BRIGHAM AND WOMEN'S HOSPITAL, MA | $132,481 | ZCA1 |
| 2019 | Functional Cancer Cell Maps1R50CA243885-01 | KREISBERG, JASON FRANCIS | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $126,633 | ZCA1 |
| 2019 | Research Specialist Support-Targeting DNA Methylation and the Cancer Epigenome1R50CA243878-01 | LIU, MINMIN | VAN ANDEL RESEARCH INSTITUTE, MI | $87,121 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.